Skip to main content

Table 3 Diagnosis, and treatment of Kawasaki disease shock syndrome and Kawasaki disease

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

 

KDSS(n=13)

KD(n=91)

P value

Diagnosis

 Initial diagnosis of KD

23.1% (3/13)

80.2% (73/91)

0.000

 Complete KD

46.2% (6/13)

67.0% (61/91)

0.214

 Incomplete KD

38.5% (5/13)

29.7% (27/91)

0.532

Treatment

 1st IVIG

84.6% (11/13)

98.9% (90/91)

0.041

 2nd IVIG

76.9% (10/13)

19.8% (18/91)

0.000

 Oral prednisolone

7.7% (1/13)

11.0% (10/91)

1.000

 Methylprednisolone pulse therapy

38.5% (5/13)

11.0% (10/91)

0.020

 Infliximab

15.4% (2/13)

0.0% (0/91)

0.015

 Antibiotics

92.3% (12/13)

15.4% (14/91)

0.000

  1. IVIG Intravenous immunoglobulin, KD Kawasaki disease, KDSS Kawasaki disease shock syndrome, SS Septic shock and toxic shock syndrome